Skip to main content Accessibility help
  • Print publication year: 2012
  • Online publication date: April 2012

Chapter 10 - Anti-dysrhythmic drugs

from Section 2 - Cardiac pharmacology

Further reading

EhrlichJR, NattelS.Atrial-selective pharmacological therapy for atrial fibrillation: Hype or Hope?Curr Opin Cardiol 2009; 24(1): 50–5.
MorrisonLJ, DeakinCD, MorleyPT, et al. 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Part 8: Advanced Life Support. Circulation 2010; 122(suppl 2): S345–421.
RieraAR, UchidaAH, FerreiraC, et al. Relationship among amiodarone, new class 3 anti-arrhythmics, miscellaneous agents and acquired long QT syndrome. Cardiol J 2008; 15(3): 209–19.
SavelievaI, CammJ. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace 2008; 10: 647–65.